Weiwen Ying is the founder of Ranok Therapeutics. Ranok Therapeutics has raised $50M in total funding. Latest round: Series B. Based in Hangzhou, China.
Weiwen Ying is the Co-Founder and CEO of Ranok Therapeutics, a pre-clinical biopharmaceutical company specializing in targeted protein degradation technology for cancer and serious diseases. He founded the company in 2018 in Hangzhou, China, and has overseen the company raise over $50 million in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library